The future of women’s health will be shaped by bold leadership, scientific innovation and cross-sector collaboration.
This exclusive Executive Roundtable will bring together a carefully curated group of senior leaders from healthcare, life sciences, government, academia, industry, investment and patient advocacy to explore how innovation, artificial intelligence and emerging technologies can transform women’s health outcomes.
Designed as an interactive, Chatham House Rule discussion, the roundtable will move beyond presentations to facilitate open, strategic dialogue between decision-makers. Together, participants will identify the key challenges, opportunities and policy priorities required to accelerate innovation, improve health equity and unlock greater investment across women’s health.
The discussion will also explore how advances in AI, digital health, precision medicine and data can enable earlier diagnosis, more personalised care and better outcomes for women throughout every stage of life.
The insights and recommendations from this Executive Roundtable will contribute to the Future of Women’s Health Executive Insight Report, helping to inform future policy discussions and support collaboration across government, healthcare and the life sciences ecosystem.
- Discussion Themes
- Women’s Health Innovation
- Artificial Intelligence & Digital Health
- Precision Medicine & Research
- Health Equity & Access
- Leadership & Cross-Sector Collaboration
- Investment & Commercialisation
- Future Workforce & Skills
- Policy Priorities for Women’s Health
Participation is by invitation only, ensuring a highly engaged discussion among senior leaders committed to shaping the future of women’s health.
Click here or click the ‘Get More Information’ button to register an interest.
Please note this is an invite only event, with limited availability. Registration of interest does not guarantee attendance. All registrations will be reviewed, and confirmed guests will receive an official confirmation email.


